Skip to main content

Clinical Trials

Study NamePISponsorDescriptionBegunStatus
Tacticath Madhu Reddy, MD SJM Post-approval study to evaluate safety of TactiCath 7/8/2015 In Follow-Up
Score Loren Berenbom, MD SJM Evaluate acute and long-term performance of market released SJM products by analyzing product survival possibilities 10/9/2012 In Follow-Up
Evolut R Trip Zorn, MD MDT New generation aortic valve for TAVR 12/12/2014 In Follow-Up
Reprise III Trip Zorn, MD BOS SCI LOTUS valve 3/12/2015 In Follow-Up
Fame3 Peter Tadros, MD Stanford University To compare CABG procedure to the implant of multiple stents 4/20/2015 Enrolling
Ilumien Peter Tadros, MD SJM To evaluate the safety and effectiveness of two devices(OCT and IVUS)  7/22/2015 In Follow-Up
Cardiac Lead Assessment Study Madhu Reddy, MD SJM Imaging study of specific SJM leads to check for malfunction 9/1/2013 In Follow-Up
COMMENCE Trial Trip Zorn, MD Edwards Dry-packed investigational valve 2/1/2014 In Follow-Up
CoreValve Continued Access Trip Zorn, MD MDT Continued access study for extreme risk patients 03/26/2012 In Follow-Up
ABSORB RCT Mark Wiley, MD AVD IDE study of a bio-resorbable coronary stent system vs XIENCE DES 8/5/2013 In Follow-
HEARTLIGHT Madhu Reddy, MD Cardiofocus IDE study of endoscopic ablation system 04/1/2012 In Follow-Up
COAPT Peter Tadros, MD AVD Mitraclip vs Standard Care 3/1/2014 In Follow-Up
Corevalve Expanded use Trip Zorn, MD MDT TAVI in high surgical risk patients 12/25/2012 In Follow-Up
PPP /PSR/SLS Martin Emert, MD MDT long-term following of FDA-Approved MDT Cardiac Rhythm Management devices 11/3/2009 Enrolling
SURTAVI Trip Zorn,MD MDT TAVI in intermediate surgical risk patients 12/25/2012 In Follow-Up
FMD Registry Kamal Gupta, MD FMDSA Registry of patients with FibromuscularDysplasia 1/2/2014 Enrolling
LEADLESS II Madhu Reddy, MD SJM Leadless Pacemaker 6/19/2014 In follow-UP
NAVIGATE X4 Martin Emert, MD BOS SCI Investigational Quadripolar Lead 9/1/2014 In Follow-Up
AMAZE Madhu Reddy, MD Sentre HEART To demonstrate that the adjunctive percutaneous LAA ligation procedure does not result in an unacceptable risk of serious adverse events (SAEs) in persistent or longstanding persistent AF subjects for whom a catheter ablation procedure is planned 11/13/2015 Enrolling
TOBA II Kamal Gupta, MD Intact Vascular TACK device in patients with PAD 1/28/2016 In Follow-Up
QP Excels Rhea Pimentel, MD Biotronik Investigational Quadripolar Lead 3/10/2016 Enrolling
WRAP-IT Martin Emert, MD Medtronic To compare the rate of major CIED infections through 12 months post-implant between the TYRX envelope group and the control group 3/10/2016 In Follow-Up
AUGUSTUS Eric Hockstad, MD Bristol-Myers Squibb To evaluate the safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and ACS or PCI 8/12/2016 In Follow-Up
cVAD Registry Peter Tadros, MD Abiomed Retrospective registry study of patients who received an Impella device 7/29/2016 Enrolling
Evolut R Low Risk Trip Zorn, MD Medtronic Evaluate the safety and effectiveness of the Medtronic TAVR System in patients with severe aortic stenosis at low risk for SAVR 8/24/2016 Enrolling
TAVR 2.0 Peter Tadros, MD Medtronic To evaluate the safety and efficacy of the Medtronic TAVR 2.0 system in SAS pts with high to extreme risk for SAVR 9/8/2016 In Follow-Up
Magnetic VT Madhu Reddy, MD Stereotaxis Comparing outcomes of  Ischemic scar ventricular VT ablation with NiobeTM ES to manual approach 8/17/2016 Enrolling
Invested Buddhadeb Dawn, MD UMW Trivalent vs Quadrivalent Flu vaccine in HF/MI pts 10/10/2016 On Hold
Adaptable Kamal Gupta, MD DCRI Virtual Clinical Trial - 81 vs 325 ASA 10/31/2016 Enrolling
Champ HF Andrew Sauer, MD Novartis Observational HF Registry 12/20/2016 In Follow-Up
AMULET Madhu Reddy, MD SJM AMPLATZERTM AmuletTM Left Atrial Appendage (LAA) Occluder
Randomized Controlled Trial - Watchman vs Amulet comparison
1/3/2017 Enrolling
CREST II Kamal Gupta, MD NIH Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis 2/21/2017 Enrolling
Prevent II Abicht Travis, MD SJM/Abbott ASA vs. Placebo post LVAD implant 4/10/2017 In Follow-Up
Pioneer Andrew Sauer, MD Novartis Inpatient initiation of Entresto vs Enalapril in rEF population 4/21/2017 In Follow-Up
Cardiomems Andrew Sauer, MD SJM/Abbott CardioMEMS HF System Post Approval Study 4/26/2017 In Follow-Up
CR in PAD Kamal Gupta, MD KU Cardiac Rehab vs Standard of Care in PAD revasc. 5/4/2017 Enrolling
VOM Madhu Reddy, MD Houston Methodist VOM ETHANOL INFUSION FOR PERSISTENT AF 5/23/2017 In Follow-Up
Atlas Trip Zorn, MD Articure LAA exclusion in open CTS procedures 5/19/2017 In Follow-Up
Siteseal Matthew Earnest, MD Wound Care 360 Site Seal Adjunctive Compression vascular closure device 7/20/2017 Enrolling
Optimum Mark Wiley, MD SLH/Bos. Sci. Outcomes of Surgically Ineligible Patients with Multivessel CAD 8/17/2017 Enrolling
Beat HF Andrew Sauer, MD CVRx, Inc. Baroreflex Activation Therapy in HFrEF 9/26/2017 Enrolling
Galactic Andrew Sauer, MD Amgen Oral inotrope in HFrEF 10/13/2017 Enrolling
Paradise Kamal Gupta, MD Medtronic Entresto post MI 11/29/2017 Enrolling
Apollo Mark Wiley, MD Medtronic Medtronic TMVR IDE 12/11/2017 Enrolling
Parallax Andrew Sauer, MD Novartis Entresto in the HFpEF population 3/22/2018 Enrolling
Emperor - P Andrew Sauer, MD BI Empagliflozin outcome trial in HFpEF 6/19/2018 Enrolling
Emperor - R Andrew Sauer, MD BI Empagliflozin outcome trial in HFrEF 6/19/2018 Enrolling
Provide HF Bhanu gupta, MD PCORI Patient Reported Outcomes in HF 3/2/2018 Enrolling
Capacity Andrew Sauer, MD Ironwood Phase II HFpEF novel compound 3/21/2018 Enrolling
Xience DAPT Eric Hockstad Abbott DAPT in HBR pts. Post XIENCE PCI 4/9/2018 Enrolling
Guide HF Andrew Sauer, MD Abbott Cardiomems in NYHA II-IV 6/20/2018 Enrolling
Last modified: Jan 28, 2020